Clinical Pearls

Personal perspectives from our expert faculty on current issues in pediatric clinical practice.

Topic:

Sort by:

For older clinical pearls, visit the archive.

- Karla Gil, MD
- Jessica Kalia, DO, FAAP, IBCLC
Infant Formula Choices
The Expanding Infant Formula Market in the US

11:30

Topics: Brain Development and Cognition DHA
- Karla Gil, MD
- Jessica Kalia, DO, FAAP, IBCLC
Infant Formula Rules and Systems
Breaking Down US Regulations for Infant Formula

13:30

Topics: Brain Development and Cognition DHA
- Tara K. Bastek, MD, MPH
- Karla Gil, MD
- Jessica Kalia, DO, FAAP, IBCLC
Infant Formula
Navigating Nutritional Differences, Labels, and Marketing

20:00

Topics: Brain Development and Cognition DHA
- John Colombo, PhD
What do the more advanced cognitive tests show related to how early exposure to DHA impacts later neurocognition? Does the timing and dose of DHA matter?

00:01:33

Topics: Brain Development and Cognition DHA
- John Colombo, PhD
Please share an overview of the history of DHA studies and outcomes related to cognitive function?

00:01:52

Topics: Brain Development and Cognition DHA
- John Colombo, PhD
Could you address the variable findings, through study design, or specifically, what is being tested in older ages? And can you connect these DHA studies to longer-term childhood cognitive outcomes?

00:01:26

Topics: Brain Development and Cognition DHA